QuickView for MDM2/MDM4 family protein binding (biogroup)

1. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
2. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. Liver Pharmacology and Xenobiotic Response Repertoire
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.
2. Structure of human MDM4 N-terminal domain bound to a single-domain antibody.
3. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.

There were no clinical trials for MDM2/MDM4 family protein binding